ORIC-I: Optimizing Recovery From Intensive Care: Mechanical Ventilation and Delirium
Status: | Completed |
---|---|
Conditions: | Neurology, Psychiatric |
Therapuetic Areas: | Neurology, Psychiatry / Psychology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 3/12/2016 |
Start Date: | March 2006 |
End Date: | December 2010 |
Contact: | Barbara J Early, BSN |
Email: | earlybj@upmc.edu |
Phone: | 412 647 9745 |
The purpose of this study is to determine if treating delirious intensive care unit patients
with haloperidol improves mortality.
with haloperidol improves mortality.
Intensive care unit delirium is a serious medical condition that is associated with
increased morbidity and mortality. In this study, 304 delirious mechanically ventilated
subjects will be randomized to haloperidol 5mg IV every 12 hours or placebo to determine if
treatment with haloperidol improves short and long-term mortality.
increased morbidity and mortality. In this study, 304 delirious mechanically ventilated
subjects will be randomized to haloperidol 5mg IV every 12 hours or placebo to determine if
treatment with haloperidol improves short and long-term mortality.
Inclusion Criteria:
- All adult (>=18 years of age) mechanically ventilated patients admitted to the
medical, surgical, trauma, or cardiothoracic ICUs of the UPMC main campus who are
expected by the ICU clinical team to require >24 hours of mechanical ventilation
Exclusion Criteria:
- Baseline QTc >480 milliseconds (ms); history of Parkinson's disease; pregnancy;
history of schizophrenia or neurologic disease that would confound the delirium
assessment; deafness or inability to understand English or Spanish; extubation prior
to enrollment; previously enrolled in this study; patient, family, or attending
physician refusal; death before enrollment; treatment with haloperidol within 2 days
prior to ICU admission; and prisoners.
We found this trial at
1
site
Click here to add this to my saved trials